Telephone: 434-243-2718; FAX: 434-244-7529
Hepatocellular carcinoma and model for end-stage liver disease exceptions: The more we understand, the more challenging the allocation gets†
Version of Record online: 29 MAR 2012
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 18, Issue 4, pages 381–383, April 2012
How to Cite
Northup, P. G. and Berg, C. L. (2012), Hepatocellular carcinoma and model for end-stage liver disease exceptions: The more we understand, the more challenging the allocation gets. Liver Transpl, 18: 381–383. doi: 10.1002/lt.23409
See Article on Page 434
- Issue online: 29 MAR 2012
- Version of Record online: 29 MAR 2012
- Accepted manuscript online: 10 FEB 2012 05:56AM EST
- Manuscript Accepted: 4 FEB 2012
- Manuscript Received: 1 FEB 2012
- 1Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN / SRTR 2010 Annual Data Report. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2011. http://www.srtr.org/annual_reports/2010/
- 4Organ Procurement and Transplantation Network. Health Resources and Services Administration, HHS. Final rule. Fed Regist 1999; 64: 56650–56661.
- 5Committee on Organ Procurement Transplantation Policy, Institute of Medicine. Organ Procurement and Transplantation: Assessing Current Policies and the Potential Impact of the DHHS Final Rule. Washington, DC: National Academies Press; 1999.